Seven signs of deadly diarrhoea disease currently spreading in UK and Europe
Cases of the unpleasant disease have risen in the UK, Ireland, Luxembourg and the Netherlands since the end of August, a health body has warned. (Source: Daily Express - Health)
Source: Daily Express - Health - October 27, 2023 Category: Consumer Health News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant
Roche will gain the rights to develop, manufacture and commercialise RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a Phase 3-ready antibody with first-in-class and best-in-disease potential, a novel mode of action and strong Phase 2b data in ulcerative colitisRoche will also obtain an option to enter into a global collaboration with Pfizer on a next-generation p40/TL1A directed bispecific antibody, currently in Phase 1Under the terms of the agreement, Roche will pay a purchase price of US$ 7.1 billion upfront and a near-term milestone payment...
Source: Roche Investor Update - October 23, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche enters into a definitive agreement to acquire Telavant including rights to novel TL1A directed antibody (RVT-3101) for the treatment of inflammatory bowel disease from Roivant
Roche will gain the rights to develop, manufacture and commercialise RVT-3101 in the US and Japan for the treatment of inflammatory bowel disease and potentially multiple other diseasesRVT-3101 is a Phase 3-ready antibody with first-in-class and best-in-disease potential, a novel mode of action and strong Phase 2b data in ulcerative colitisRoche will also obtain an option to enter into a global collaboration with Pfizer on a next-generation p40/TL1A directed bispecific antibody, currently in Phase 1Under the terms of the agreement, Roche will pay a purchase price of US$ 7.1 billion upfront and a near-term milestone payment...
Source: Roche Media News - October 23, 2023 Category: Pharmaceuticals Source Type: news
South Asian Community Health Workers Say Their Work is Work
Community health workers demand to be recognised as formal workers with pay and benefits to match. Credit: Zofeen T. EbrahimBy Zofeen EbrahimKARACHI, Oct 19 2023 (IPS) “Professionally, I am still where I was 23 years ago when I started working as a lady health worker (LHW),” said a disgruntled Yasmin Siddiq, 47, from Karachi. “I will probably retire in the same capacity, as a Grade 5 government servant, without any hope for upward mobility.”
The idea behind the Lady Health Worker Programme (LHWP), the brainchild of Pakistan’s late prime minister Benazir Bhutto, began in 1994 with the purpose of “training women...
Source: IPS Inter Press Service - Health - October 19, 2023 Category: International Medicine & Public Health Authors: Zofeen Ebrahim Tags: Asia-Pacific Editors' Choice Featured Gender Headlines Health Human Rights Inequality TerraViva United Nations Women's Health IPS UN Bureau IPS UN Bureau Report Pakistan South Asia Source Type: news
Kenya: 120 Amabuko Secondary School Students Hospitalised Due to Food Poisoning
[Capital FM] Kisii -- 120 Amabuko Mixed Secondary School students in Nyaribari Masaba Constituency, Kisii County, were rushed to hospitals today after being taken ill of diarrhoea and stomach upsets. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 17, 2023 Category: African Health Tags: East Africa Education Health and Medicine Kenya Nutrition Source Type: news
People may suffer ‘long colds’ more than four weeks after infection, study shows
Results in the Lancet ’s EClinicalMedicine journal found a ‘similar risk’ of long-term symptoms as those with CovidScientists say they have found evidence that people may experience “long colds”, acute respiratory infections with long-term symptoms.Some of the most common symptoms include coughing, stomach pain, and diarrhoea more than four weeks after the initial infection. The severity of an illness appears to be a key driver of risk of long-term symptoms.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 6, 2023 Category: Science Authors: Andrew Gregory Health editor Tags: Medical research Common cold Flu Coronavirus Infectious diseases Science UK news Source Type: news
'Long colds' are a thing, like long Covid say experts
Common 'long cold' symptoms people reported include a cough, stomach pain, and diarrhoea. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 6, 2023 Category: Consumer Health News Source Type: news
Sudan: Dengue Fever, Cholera, and Measles On the Rise in Sudan
[Dabanga] El Gedaref / El Gezira / Khartoum / Omdurman -- The federal Ministry of Health, working from Port Sudan, capital of Red Sea state, has registered hundreds of suspected cases of dengue fever and watery diarrhoea in El Gedaref and El Gezira. Cholera and measles have been reported elsewhere in Sudan. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 28, 2023 Category: African Health Tags: East Africa Health and Medicine Sudan Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Media News - August 29, 2023 Category: Pharmaceuticals Source Type: news
European Commission approves Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment2,3Evrysdi is the only non-invasive SMA therapy and is approved in 100 countries with more than 11,000 patients treated globallyBasel, 29 August 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved the extension of the Evrysdi ® (risdiplam) European Union (EU) marketing ...
Source: Roche Investor Update - August 29, 2023 Category: Pharmaceuticals Source Type: news
Father-of-four diagnosed with bowel cancer months after doctors dismissed his symptoms as anaemia
EXCLUSIVE: Matt Jones, from Kent, visited his GP in May after suffering from extreme cramping, diarrhoea and nausea. But his symptoms were dismissed as anaemia. (Source: the Mail online | Health)
Source: the Mail online | Health - August 24, 2023 Category: Consumer Health News Source Type: news
Floods, Now Torrential Monsoon Rains Leave Pakistani Women in Crisis
Women outside an emergency vehicle aimed at helping those affected by flooding. CREDIT: Ashfaq Yusufzai/IPSBy Ashfaq YusufzaiPESHAWAR, PAKISTAN , Aug 18 2023 (IPS) Torrential monsoon rains have left the people, especially women, in crisis as they are still grappling to recover from the last year’s floods in Pakistan.
“We are yet to return to normal lives after devastation caused by severe rains in June 2002 when the new series of rains have started only to further aggravate our problems,” Jannat Bibi, a resident of Kalam in the Swat Valley, told IPS.
Bibi, 44, a housewife, along with co-villagers, must walk about a ...
Source: IPS Inter Press Service - Health - August 18, 2023 Category: International Medicine & Public Health Authors: Ashfaq Yusufzai Tags: Asia-Pacific Climate Change Development & Aid Environment Featured Headlines Health Humanitarian Emergencies Poverty & SDGs TerraViva United Nations IPS UN Bureau IPS UN Bureau Report Pakistan Source Type: news
Hunt for mystery 'contaminated food' behind killer E. coli outbreak striking kids: Health chiefs admit they have no idea what's to blame
Twenty-five people - the majority of whom are children - have been sickened by an extremely rare strain of the diarrhoea-causing bug since the end of May. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2023 Category: Consumer Health News Source Type: news
Urgent warning to parents over mysterious E. coli outbreak that has killed one Brit and hospitalised six - as health chiefs say it is predominantly striking kids
Since the end of May, 25 people in the UK have tested positive for a 'very rare' strain of E Coli that causes diarrhoea, stomach cramps and a fever, according to the UK Health Security Agency. (Source: the Mail online | Health)
Source: the Mail online | Health - August 7, 2023 Category: Consumer Health News Source Type: news
CHMP recommends Roche ’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
Positive recommendation is based on interim data from ongoing RAINBOWFISH trial which showed majority ofEvrysdi-treated babies were able to stand and walk within timeframes typical of healthy babies by 12 months ’ treatment1,2If approved by the European Commission,Evrysdi will be available to treat people of all ages with SMA in the European Union, including babies from birthEvrysdi is now approved in 100 countries with more than 8,500 patients treated globallyBasel, 21 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive o...
Source: Roche Media News - July 21, 2023 Category: Pharmaceuticals Source Type: news
